Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Kass

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Ophthalmology|June 5, 2018
ReplyMae O Gordon, Michael A Kass
American Journal of Ophthalmology|March 5, 2018
What We Have Learned From the Ocular Hypertension Treatment StudyMae O Gordon, Michael A Kass
JAMA Ophthalmology|August 12, 2021
Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study (OHTS)-ReplyMichael A Kass, Mae O Gordon
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2008
Diabetes and glaucomaMichael A Kass, Mae O Gordon,
JAMA Ophthalmology|March 17, 2017
Anti-VEGF Injections and Glaucoma SurgeryRajendra S Apte, Mae Gordon, Michael A Kass
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 13, 2005
Incorporating the results of the Ocular Hypertension Treatment Study into clinical practiceMichael A Kass, Mae O Gordon, Steven M Kymes
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 13, 2008
Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?Mae O Gordon, Julia A Beiser, Michael A Kass, et al.
Ophthalmology|January 30, 2013
Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment studyStuart K Gardiner, Shaban Demirel, Mae O Gordon, et al.
American Journal of Ophthalmology|November 9, 2004
Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment StudyJames D Brandt, Julia A Beiser, Mae O Gordon, et al.
Ophthalmology|March 24, 2020
Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS)James D Brandt, Julia A Beiser, Michael A Kass, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Ophthalmology|June 5, 2018
ReplyMae O Gordon, Michael A Kass
American Journal of Ophthalmology|March 5, 2018
What We Have Learned From the Ocular Hypertension Treatment StudyMae O Gordon, Michael A Kass
JAMA Ophthalmology|August 12, 2021
Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study (OHTS)-ReplyMichael A Kass, Mae O Gordon
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2008
Diabetes and glaucomaMichael A Kass, Mae O Gordon,
JAMA Ophthalmology|March 17, 2017
Anti-VEGF Injections and Glaucoma SurgeryRajendra S Apte, Mae Gordon, Michael A Kass
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 13, 2005
Incorporating the results of the Ocular Hypertension Treatment Study into clinical practiceMichael A Kass, Mae O Gordon, Steven M Kymes
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 13, 2008
Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?Mae O Gordon, Julia A Beiser, Michael A Kass, et al.
Ophthalmology|January 30, 2013
Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment studyStuart K Gardiner, Shaban Demirel, Mae O Gordon, et al.
American Journal of Ophthalmology|November 9, 2004
Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment StudyJames D Brandt, Julia A Beiser, Mae O Gordon, et al.
Ophthalmology|March 24, 2020
Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS)James D Brandt, Julia A Beiser, Michael A Kass, et al.
Pageof 7